[1]
F. Ole Larsen, M. Karsbøl Boisen, A. L. Fromm, and B. Vittrup Jensen, “Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer”, AO, vol. 51, no. 2, pp. 231–233, Feb. 2012.